Weekly Topotecan With Docetaxel in Recurrent Small Cell Lung Cancer
Status:
Terminated
Trial end date:
2007-11-08
Target enrollment:
Participant gender:
Summary
The purposes of this study are:
- To determine the overall response rate of patients treated with at least 2 cycles of
this regimen.
- To determine the feasibility and toxicity of the combination of topotecan and docetaxel.